<DOC>
	<DOCNO>NCT01474486</DOCNO>
	<brief_summary>The purpose project conduct preliminary test feasibility multi-micronutrient intervention improve micronutrient status , cardiac function quality life Veterans Congestive Heart Failure ( CHF ) .</brief_summary>
	<brief_title>Feasibility Effectiveness Micronutrients Palliative Care Therapy Patients With Congestive Heart Failure</brief_title>
	<detailed_description>Veterans stable CHF result ischemic cardiomyopathy systolic dysfunction ejection fraction ≤45 % fit criterion stage B , C D 2 heart failure recruit . This one group study Veterans serve control . They receive 50 mg thiamin , vitamin B50 220 mg Zn Zn sulfate daily 6 month . Additionally , receive 50,000 IU Vitamin D ergocalciferol week 8 week every week 16 week . Pre ( baseline ) post ( 6 month ) cardiac function test echocardiogram cardiac MR ( applicable ) , biochemical measure thiamine , pyridoxine , zinc Vitamin D measure baseline , 3 month , 6 month one year . Quality life measure use Minnesota Living Heart Failure questionnaire baseline , month 3,6 , one year . Nutritional assessment include nutrition focus physical examination three day food record also measure baseline , month 3 , 6 one year .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Pantothenic Acid</mesh_term>
	<mesh_term>Thiamine</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Micronutrients</mesh_term>
	<mesh_term>Trace Elements</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>stable CHF ( three month without exacerbation major change medication regimen cardiology provider determine medication regimen ( angiotensin II receptor blocker ( ARBs ) , aldosterone , angiotensin convert enzyme ( ACE ) inhibitor Beta blocker ) maximize ) , Stage B , C D CHF result ischemic cardiomyopathy ejection fraction ≤ 45 % without pacemaker defibrillator . Potential participant require medication titration attain maximal benefit , need wait 30 day provider maximize dose medication participate . recent ( within last three month ) acute myocardial infarction , unstable angina , pacemaker defibrillator place less six month prior , anticipated pacemaker defibrillator placement next six month , bi ventricular pacemaker , corticosteroid use ( &gt; 20 mg Prednisone use equivalent per day &gt; 2 week duration ) , isoniazid therapy , use study nutrition supplement study dos past month longer , ( participant take multivitamin multivitamin mineral , water soluble vitamin need stop take least one month prior initiate study intervention ) , endstage liver disease , endstage renal disease require dialysis , receive chemotherapy radiation therapy , active alcohol/ substance abuse , pregnancy /lactation , woman childbearing potential medical documentation surgically induced menopause , pancreatitis , psychological issue like severe depression , claustrophobia , active problematic posttraumatic stress disorder ( PTSD ) , memory loss prevents compliance supplement intake , agoraphobia may interfere attendance research visit fear needle would limit ability blood test complete , active eating disorder . Cardiac Magnetic Resonance Imaging ( MRI ) scan use test cardiac function participant pacemaker defibrillator . Nor used potential subject ferro magnetic material ( i.e. , penile stimulator ) , inability lie flat one hour , inability hold breath 15 second claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>thiamin</keyword>
	<keyword>pyridoxine</keyword>
	<keyword>vitamin D</keyword>
	<keyword>zinc</keyword>
	<keyword>congestive heart failure ( CHF )</keyword>
	<keyword>ischemic cardiomyopathy</keyword>
	<keyword>nutritional injury</keyword>
	<keyword>quality life</keyword>
</DOC>